TABLE 2.
Log-transformed Joinpoint trends in ovarian cancer incidence by histotype and race/ethnicity, SEER-12, 1992–2019
| Trend 1 | Trend 2 | Trend 3 | 2015–2019 AAPC (95% CI) |
2010–2019 AAPC (95% CI) |
|||||
|---|---|---|---|---|---|---|---|---|---|
| Histotype | Race/ethnicity | Years | APC (95% CI) | Years | APC (95% CI) | Years | APC (95% CI) | ||
| High-grade serous | Asian/Pacific Islander | 1992–2019 | −1.1 (−1.8 to −0.5)a | −1.1 (−1.8 to −0.5)a | −1.1 (−1.8 to −0.5)a | ||||
| Hispanic | 1992–2019 | −0.7 (−1.2 to −0.1)a | −0.7 (−1.2 to −0.1)a | −0.7 (−1.2 to −0.1)a | |||||
| Non-Hispanic Black | 1992–2019 | −1.1 (−1.9 to −0.2)a | −1.1 (−1.9 to −0.2)a | −1.1 (−1.9 to −0.2)a | |||||
| Non-Hispanic White | 1992–1998 | 0.8 (−1.8 to 3.4) | 1998–2015 | −2.1 (−2.7 to −1.5)a | 2015–2019 | −10.9 (−15.1 to −6.5)a | −10.9 (−15.1 to −6.5)a | −6.1 (−8.0 to −4.2)a | |
| Low-grade endometrioid | Asian/Pacific Islander | 1992–2019 | 0.4 (−0.8 to 1.6) | 0.4 (−0.8 to 1.6) | 0.4 (−0.8 to 1.6) | ||||
| Hispanic | 1992–1998 | 12.7 (0.8 to 26.0)a | 1998–2003 | −12.6 (−29.0 to 7.7) | 2003–2019 | 3.6 (1.0 to 6.3)a | 3.6 (1.0 to 6.3)a | 3.6 (1.0 to 6.3)a | |
| Non-Hispanic Black | 1992–2019 | −1.2 (−3.6 to 1.2) | −1.2 (−3.6 to 1.2) | −1.2 (−3.6 to 1.2) | |||||
| Non-Hispanic White | 1992–2019 | −1.3 (−1.9 to −0.8)a | −1.3 (−1.9 to −0.8)a | −1.3 (−1.9 to −0.8)a | |||||
| Clear cell | Asian/Pacific Islander | 1992–2019 | 1.5 (0.7 to 2.2)a | 1.5 (0.7 to 2.2)a | 1.5 (0.7 to 2.2)a | ||||
| Hispanic | 1992–2019 | 2.8 (0.8 to 4.7)a | 2.8 (0.8 to 4.7)a | 2.8 (0.8 to 4.7)a | |||||
| Non-Hispanic Black | 1992–2019 | 1.3 (−1.1 to 3.7) | 1.3 (−1.1 to 3.7) | 1.3 (−1.1 to 3.7) | |||||
| Non-Hispanic White | 1992–2019 | 0.3 (−0.3 to 1.0) | 0.3 (−0.3 to 1.0) | 0.3 (−0.3 to 1.0) | |||||
aStatistically significant (P < 0.05).